Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 170 | 2023 | 772 | 37.850 |
Why?
|
Homosexuality, Male | 122 | 2023 | 298 | 28.510 |
Why?
|
Pre-Exposure Prophylaxis | 52 | 2023 | 137 | 19.400 |
Why?
|
Sexual and Gender Minorities | 51 | 2023 | 192 | 12.810 |
Why?
|
Anti-HIV Agents | 28 | 2023 | 149 | 10.820 |
Why?
|
Social Networking | 39 | 2023 | 75 | 10.570 |
Why?
|
Sexual Behavior | 56 | 2023 | 302 | 9.270 |
Why?
|
Chicago | 64 | 2023 | 1379 | 5.870 |
Why?
|
Social Support | 25 | 2020 | 193 | 5.720 |
Why?
|
Transgender Persons | 14 | 2022 | 95 | 5.500 |
Why?
|
Risk-Taking | 35 | 2021 | 148 | 5.000 |
Why?
|
Contact Tracing | 12 | 2023 | 29 | 4.770 |
Why?
|
Young Adult | 104 | 2023 | 5976 | 4.650 |
Why?
|
Syphilis | 8 | 2023 | 27 | 4.450 |
Why?
|
Disease Transmission, Infectious | 11 | 2019 | 57 | 4.290 |
Why?
|
Medication Adherence | 11 | 2022 | 129 | 4.110 |
Why?
|
Male | 183 | 2023 | 40966 | 3.930 |
Why?
|
Patient Acceptance of Health Care | 16 | 2020 | 238 | 3.870 |
Why?
|
Sexual Partners | 23 | 2023 | 93 | 3.830 |
Why?
|
Sexually Transmitted Diseases | 14 | 2023 | 91 | 3.720 |
Why?
|
Unsafe Sex | 17 | 2023 | 42 | 3.680 |
Why?
|
Adolescent | 84 | 2023 | 8981 | 3.430 |
Why?
|
Adult | 142 | 2023 | 25648 | 3.420 |
Why?
|
Health Knowledge, Attitudes, Practice | 24 | 2021 | 508 | 3.410 |
Why?
|
Continuity of Patient Care | 9 | 2021 | 169 | 3.150 |
Why?
|
Humans | 224 | 2023 | 86644 | 2.970 |
Why?
|
Residence Characteristics | 10 | 2020 | 197 | 2.840 |
Why?
|
Social Stigma | 11 | 2021 | 52 | 2.600 |
Why?
|
HIV-1 | 8 | 2021 | 163 | 2.500 |
Why?
|
Safe Sex | 7 | 2020 | 23 | 2.330 |
Why?
|
Substance-Related Disorders | 10 | 2023 | 394 | 2.310 |
Why?
|
Health Promotion | 10 | 2020 | 160 | 2.270 |
Why?
|
Criminals | 3 | 2020 | 33 | 2.080 |
Why?
|
HIV Seropositivity | 8 | 2020 | 49 | 1.990 |
Why?
|
Acquired Immunodeficiency Syndrome | 5 | 2023 | 78 | 1.940 |
Why?
|
Viral Load | 10 | 2020 | 148 | 1.940 |
Why?
|
Papillomavirus Infections | 7 | 2022 | 239 | 1.890 |
Why?
|
Internet | 7 | 2021 | 312 | 1.690 |
Why?
|
Circumcision, Male | 5 | 2013 | 18 | 1.660 |
Why?
|
Peer Group | 6 | 2021 | 72 | 1.660 |
Why?
|
Female | 81 | 2023 | 44533 | 1.650 |
Why?
|
Health Status Disparities | 6 | 2020 | 170 | 1.590 |
Why?
|
India | 17 | 2018 | 120 | 1.540 |
Why?
|
Socioeconomic Factors | 15 | 2020 | 567 | 1.520 |
Why?
|
Automobile Driving | 5 | 2014 | 31 | 1.500 |
Why?
|
Referral and Consultation | 6 | 2021 | 328 | 1.470 |
Why?
|
Logistic Models | 17 | 2020 | 1186 | 1.440 |
Why?
|
Criminal Law | 4 | 2021 | 11 | 1.410 |
Why?
|
Social Media | 4 | 2020 | 79 | 1.370 |
Why?
|
Condoms | 7 | 2019 | 36 | 1.350 |
Why?
|
United States | 32 | 2023 | 6672 | 1.340 |
Why?
|
Risk Factors | 24 | 2023 | 5417 | 1.310 |
Why?
|
Longitudinal Studies | 15 | 2020 | 1019 | 1.250 |
Why?
|
Anus Neoplasms | 3 | 2019 | 30 | 1.250 |
Why?
|
Middle Aged | 54 | 2022 | 25028 | 1.250 |
Why?
|
Cohort Studies | 18 | 2023 | 2767 | 1.220 |
Why?
|
Cross-Sectional Studies | 20 | 2023 | 1621 | 1.180 |
Why?
|
Substance Abuse, Intravenous | 7 | 2021 | 54 | 1.180 |
Why?
|
Opioid-Related Disorders | 8 | 2022 | 161 | 1.170 |
Why?
|
HIV Seronegativity | 3 | 2020 | 12 | 1.170 |
Why?
|
Cell Phone | 4 | 2018 | 37 | 1.170 |
Why?
|
Stress, Psychological | 6 | 2021 | 313 | 1.100 |
Why?
|
Crime | 3 | 2020 | 36 | 1.070 |
Why?
|
Prevalence | 16 | 2022 | 1239 | 1.060 |
Why?
|
Motor Vehicles | 4 | 2012 | 18 | 1.060 |
Why?
|
Health Services Accessibility | 8 | 2022 | 394 | 1.060 |
Why?
|
Family Relations | 2 | 2016 | 35 | 1.030 |
Why?
|
Incidence | 12 | 2022 | 1577 | 0.980 |
Why?
|
Coinfection | 3 | 2022 | 58 | 0.980 |
Why?
|
HIV | 8 | 2022 | 46 | 0.970 |
Why?
|
Cannabis | 2 | 2023 | 34 | 0.960 |
Why?
|
Violence | 2 | 2018 | 143 | 0.960 |
Why?
|
Health Surveys | 8 | 2019 | 239 | 0.920 |
Why?
|
Herpes Genitalis | 3 | 2015 | 41 | 0.910 |
Why?
|
Hand Disinfection | 2 | 2021 | 17 | 0.910 |
Why?
|
Papillomaviridae | 4 | 2022 | 153 | 0.890 |
Why?
|
Skin Pigmentation | 3 | 2022 | 40 | 0.890 |
Why?
|
Surveys and Questionnaires | 19 | 2022 | 2501 | 0.880 |
Why?
|
Social Capital | 2 | 2021 | 3 | 0.840 |
Why?
|
Social Work | 2 | 2019 | 19 | 0.840 |
Why?
|
Viremia | 1 | 2021 | 54 | 0.810 |
Why?
|
Urban Population | 5 | 2018 | 213 | 0.810 |
Why?
|
Sexuality | 1 | 2021 | 40 | 0.810 |
Why?
|
Masks | 1 | 2021 | 29 | 0.810 |
Why?
|
Ambulatory Care Facilities | 3 | 2020 | 102 | 0.800 |
Why?
|
Travel | 2 | 2018 | 68 | 0.800 |
Why?
|
Interpersonal Relations | 4 | 2020 | 170 | 0.800 |
Why?
|
Emergency Service, Hospital | 4 | 2023 | 484 | 0.800 |
Why?
|
Motivation | 4 | 2019 | 287 | 0.800 |
Why?
|
Anus Diseases | 2 | 2022 | 14 | 0.790 |
Why?
|
Racism | 3 | 2019 | 81 | 0.790 |
Why?
|
Sleep Wake Disorders | 1 | 2022 | 115 | 0.770 |
Why?
|
Risk Assessment | 7 | 2020 | 2261 | 0.770 |
Why?
|
Electronic Health Records | 5 | 2023 | 319 | 0.740 |
Why?
|
Bisexuality | 6 | 2020 | 32 | 0.740 |
Why?
|
Drug Prescriptions | 2 | 2020 | 141 | 0.740 |
Why?
|
Resilience, Psychological | 1 | 2020 | 23 | 0.730 |
Why?
|
Primary Prevention | 1 | 2020 | 85 | 0.720 |
Why?
|
Exposure to Violence | 2 | 2018 | 12 | 0.720 |
Why?
|
Healthcare Disparities | 5 | 2019 | 371 | 0.700 |
Why?
|
Epidemics | 2 | 2018 | 33 | 0.680 |
Why?
|
Delivery of Health Care | 3 | 2019 | 426 | 0.680 |
Why?
|
Health Behavior | 4 | 2021 | 183 | 0.670 |
Why?
|
Texas | 7 | 2022 | 101 | 0.670 |
Why?
|
Sex Workers | 2 | 2021 | 9 | 0.660 |
Why?
|
Heterosexuality | 1 | 2018 | 17 | 0.660 |
Why?
|
Diagnostic Tests, Routine | 2 | 2017 | 62 | 0.660 |
Why?
|
Communicable Disease Control | 2 | 2021 | 51 | 0.660 |
Why?
|
Patient Compliance | 4 | 2021 | 227 | 0.650 |
Why?
|
Gender Identity | 3 | 2023 | 52 | 0.650 |
Why?
|
Models, Psychological | 2 | 2016 | 157 | 0.640 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 59 | 0.630 |
Why?
|
Mass Screening | 7 | 2021 | 618 | 0.630 |
Why?
|
Academic Medical Centers | 1 | 2020 | 379 | 0.630 |
Why?
|
Public Health Surveillance | 1 | 2018 | 21 | 0.630 |
Why?
|
Reproductive Health | 1 | 2018 | 32 | 0.610 |
Why?
|
Greece | 8 | 2022 | 19 | 0.610 |
Why?
|
Text Messaging | 2 | 2015 | 27 | 0.600 |
Why?
|
Uncertainty | 1 | 2017 | 71 | 0.590 |
Why?
|
Anti-Retroviral Agents | 4 | 2018 | 30 | 0.590 |
Why?
|
Louisiana | 4 | 2020 | 17 | 0.590 |
Why?
|
Penile Neoplasms | 1 | 2016 | 10 | 0.590 |
Why?
|
Health Status | 3 | 2019 | 360 | 0.580 |
Why?
|
Marijuana Use | 1 | 2016 | 6 | 0.580 |
Why?
|
Rural Population | 6 | 2023 | 136 | 0.570 |
Why?
|
Health Care Reform | 1 | 2017 | 90 | 0.560 |
Why?
|
Tenofovir | 3 | 2022 | 7 | 0.550 |
Why?
|
Urban Health | 2 | 2013 | 55 | 0.550 |
Why?
|
Communication | 2 | 2019 | 441 | 0.540 |
Why?
|
Mother-Child Relations | 1 | 2015 | 26 | 0.540 |
Why?
|
Psychoanalytic Therapy | 1 | 2015 | 3 | 0.530 |
Why?
|
Psychoanalytic Theory | 1 | 2015 | 9 | 0.530 |
Why?
|
Group Processes | 1 | 2015 | 31 | 0.520 |
Why?
|
Chemoprevention | 1 | 2015 | 91 | 0.520 |
Why?
|
Thinking | 1 | 2015 | 33 | 0.510 |
Why?
|
Social Identification | 1 | 2015 | 24 | 0.510 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2016 | 118 | 0.510 |
Why?
|
Bias | 2 | 2020 | 127 | 0.510 |
Why?
|
Sociometric Techniques | 1 | 2014 | 3 | 0.500 |
Why?
|
Self Disclosure | 1 | 2014 | 31 | 0.500 |
Why?
|
Spinal Injuries | 1 | 2014 | 22 | 0.500 |
Why?
|
Women's Health | 1 | 2015 | 100 | 0.490 |
Why?
|
Multiple Trauma | 1 | 2014 | 34 | 0.490 |
Why?
|
Electronic Mail | 1 | 2014 | 14 | 0.490 |
Why?
|
Quality Improvement | 2 | 2017 | 428 | 0.480 |
Why?
|
Patient Participation | 1 | 2016 | 216 | 0.480 |
Why?
|
Transportation | 3 | 2013 | 18 | 0.480 |
Why?
|
Complementary Therapies | 1 | 2014 | 54 | 0.480 |
Why?
|
Cervical Vertebrae | 1 | 2014 | 79 | 0.470 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 275 | 0.470 |
Why?
|
Restaurants | 1 | 2013 | 5 | 0.470 |
Why?
|
Wounds, Nonpenetrating | 1 | 2014 | 92 | 0.460 |
Why?
|
Interviews as Topic | 6 | 2019 | 319 | 0.460 |
Why?
|
Mexican Americans | 1 | 2013 | 63 | 0.450 |
Why?
|
Multivariate Analysis | 5 | 2021 | 999 | 0.450 |
Why?
|
Decision Making | 2 | 2016 | 642 | 0.450 |
Why?
|
Comorbidity | 5 | 2023 | 943 | 0.440 |
Why?
|
Friends | 1 | 2012 | 17 | 0.430 |
Why?
|
Seroepidemiologic Studies | 4 | 2019 | 55 | 0.430 |
Why?
|
Marriage | 1 | 2012 | 26 | 0.420 |
Why?
|
Depression | 1 | 2016 | 473 | 0.420 |
Why?
|
Pandemics | 6 | 2022 | 740 | 0.410 |
Why?
|
Perception | 4 | 2020 | 168 | 0.400 |
Why?
|
Video Recording | 1 | 2012 | 190 | 0.400 |
Why?
|
Drug Users | 3 | 2021 | 19 | 0.400 |
Why?
|
Aged | 13 | 2021 | 18415 | 0.390 |
Why?
|
Counseling | 1 | 2012 | 145 | 0.390 |
Why?
|
Quality of Health Care | 4 | 2017 | 380 | 0.390 |
Why?
|
Prisoners | 2 | 2023 | 40 | 0.380 |
Why?
|
Population Dynamics | 1 | 2011 | 130 | 0.380 |
Why?
|
Retrospective Studies | 6 | 2021 | 8489 | 0.380 |
Why?
|
Drug Overdose | 2 | 2022 | 65 | 0.380 |
Why?
|
Risk Reduction Behavior | 4 | 2018 | 98 | 0.370 |
Why?
|
Central Nervous System Stimulants | 2 | 2023 | 216 | 0.360 |
Why?
|
Health Services Research | 2 | 2008 | 136 | 0.360 |
Why?
|
Self Efficacy | 2 | 2022 | 53 | 0.360 |
Why?
|
Pharmaceutical Preparations | 2 | 2021 | 92 | 0.350 |
Why?
|
Cities | 5 | 2022 | 40 | 0.350 |
Why?
|
Poverty | 2 | 2021 | 173 | 0.340 |
Why?
|
Hygiene | 1 | 2009 | 10 | 0.340 |
Why?
|
Age Factors | 3 | 2018 | 1851 | 0.330 |
Why?
|
Nitrites | 2 | 2018 | 30 | 0.330 |
Why?
|
AIDS Serodiagnosis | 2 | 2020 | 25 | 0.330 |
Why?
|
Minority Groups | 2 | 2022 | 137 | 0.320 |
Why?
|
Male Urogenital Diseases | 1 | 2007 | 9 | 0.320 |
Why?
|
Gingiva | 1 | 2007 | 8 | 0.320 |
Why?
|
Insurance, Health | 2 | 2020 | 160 | 0.320 |
Why?
|
AIDS Vaccines | 1 | 2007 | 9 | 0.320 |
Why?
|
Alcoholism | 2 | 2020 | 172 | 0.320 |
Why?
|
Female Urogenital Diseases | 1 | 2007 | 9 | 0.320 |
Why?
|
HIV Antibodies | 1 | 2007 | 25 | 0.310 |
Why?
|
Rural Health | 1 | 2007 | 20 | 0.310 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2008 | 64 | 0.310 |
Why?
|
Sex Work | 3 | 2018 | 12 | 0.310 |
Why?
|
Trust | 3 | 2023 | 95 | 0.310 |
Why?
|
Cervix Uteri | 1 | 2007 | 65 | 0.310 |
Why?
|
Schools | 2 | 2021 | 71 | 0.300 |
Why?
|
France | 7 | 2019 | 47 | 0.290 |
Why?
|
Gift Giving | 1 | 2006 | 5 | 0.290 |
Why?
|
Pilot Projects | 2 | 2021 | 839 | 0.290 |
Why?
|
Odds Ratio | 5 | 2018 | 678 | 0.280 |
Why?
|
Illinois | 4 | 2020 | 462 | 0.280 |
Why?
|
Community-Based Participatory Research | 2 | 2020 | 36 | 0.280 |
Why?
|
Drug Industry | 1 | 2006 | 54 | 0.270 |
Why?
|
Sex Factors | 3 | 2020 | 1054 | 0.270 |
Why?
|
Social Perception | 1 | 2006 | 95 | 0.270 |
Why?
|
Geography | 2 | 2021 | 223 | 0.270 |
Why?
|
Analgesics, Opioid | 4 | 2023 | 413 | 0.270 |
Why?
|
Patient-Centered Care | 2 | 2019 | 203 | 0.260 |
Why?
|
Cluster Analysis | 3 | 2021 | 369 | 0.260 |
Why?
|
Alcohol Drinking | 2 | 2019 | 267 | 0.260 |
Why?
|
HIV Seroprevalence | 2 | 2018 | 9 | 0.250 |
Why?
|
Phylogeny | 6 | 2020 | 1137 | 0.250 |
Why?
|
Attitude | 3 | 2022 | 127 | 0.250 |
Why?
|
Models, Theoretical | 5 | 2021 | 482 | 0.250 |
Why?
|
Hospitals, Rural | 1 | 2004 | 5 | 0.240 |
Why?
|
Time Factors | 4 | 2019 | 5210 | 0.240 |
Why?
|
Ethics, Medical | 1 | 2006 | 306 | 0.230 |
Why?
|
Occupational Health | 2 | 2014 | 32 | 0.230 |
Why?
|
Health Risk Behaviors | 2 | 2020 | 5 | 0.230 |
Why?
|
Anal Canal | 3 | 2022 | 89 | 0.230 |
Why?
|
Otolaryngology | 3 | 2016 | 53 | 0.220 |
Why?
|
Sexual Health | 1 | 2023 | 14 | 0.220 |
Why?
|
Patient Transfer | 1 | 2004 | 91 | 0.220 |
Why?
|
Herpesvirus 2, Human | 2 | 2015 | 45 | 0.220 |
Why?
|
Smartphone | 3 | 2019 | 36 | 0.220 |
Why?
|
Internal Medicine | 1 | 2006 | 347 | 0.220 |
Why?
|
Quality Indicators, Health Care | 1 | 2004 | 144 | 0.210 |
Why?
|
Vulnerable Populations | 2 | 2020 | 76 | 0.210 |
Why?
|
Geographic Information Systems | 2 | 2019 | 20 | 0.210 |
Why?
|
Infectious Disease Medicine | 1 | 2021 | 7 | 0.210 |
Why?
|
Program Evaluation | 2 | 2014 | 297 | 0.210 |
Why?
|
Data Collection | 2 | 2014 | 372 | 0.210 |
Why?
|
Capacity Building | 1 | 2021 | 10 | 0.200 |
Why?
|
Rhinitis | 2 | 2017 | 175 | 0.200 |
Why?
|
Human papillomavirus 18 | 2 | 2022 | 16 | 0.200 |
Why?
|
Public Health | 3 | 2022 | 129 | 0.200 |
Why?
|
Human papillomavirus 16 | 2 | 2022 | 38 | 0.200 |
Why?
|
Emtricitabine | 1 | 2020 | 2 | 0.200 |
Why?
|
San Francisco | 1 | 2020 | 21 | 0.200 |
Why?
|
Sinusitis | 2 | 2017 | 210 | 0.190 |
Why?
|
Prospective Studies | 4 | 2023 | 4214 | 0.190 |
Why?
|
DNA, Viral | 2 | 2018 | 265 | 0.190 |
Why?
|
Health Education | 2 | 2019 | 101 | 0.190 |
Why?
|
Probability | 1 | 2021 | 355 | 0.190 |
Why?
|
Rural Health Services | 1 | 2020 | 13 | 0.190 |
Why?
|
Natural Language Processing | 1 | 2021 | 37 | 0.190 |
Why?
|
Mentoring | 1 | 2021 | 30 | 0.190 |
Why?
|
Intensive Care Units | 1 | 2004 | 373 | 0.190 |
Why?
|
Social Norms | 1 | 2019 | 9 | 0.180 |
Why?
|
Psychological Theory | 1 | 2020 | 22 | 0.180 |
Why?
|
Psychotherapy, Brief | 1 | 2020 | 10 | 0.180 |
Why?
|
Universities | 2 | 2019 | 135 | 0.180 |
Why?
|
Hospitals, Urban | 1 | 2020 | 54 | 0.180 |
Why?
|
Follow-Up Studies | 3 | 2018 | 3640 | 0.180 |
Why?
|
Marijuana Smoking | 2 | 2018 | 29 | 0.180 |
Why?
|
Treatment Outcome | 5 | 2020 | 7993 | 0.180 |
Why?
|
Atherosclerosis | 2 | 2020 | 244 | 0.180 |
Why?
|
Eligibility Determination | 1 | 2019 | 32 | 0.170 |
Why?
|
Public Health Practice | 1 | 2019 | 11 | 0.170 |
Why?
|
Forecasting | 1 | 2020 | 304 | 0.170 |
Why?
|
Cooperative Behavior | 2 | 2019 | 174 | 0.170 |
Why?
|
Patient Navigation | 1 | 2019 | 12 | 0.170 |
Why?
|
Housing | 1 | 2019 | 42 | 0.170 |
Why?
|
Professional-Patient Relations | 1 | 2019 | 53 | 0.170 |
Why?
|
Health Expenditures | 1 | 2020 | 86 | 0.170 |
Why?
|
Community Health Centers | 1 | 2020 | 113 | 0.170 |
Why?
|
Awareness | 1 | 2019 | 93 | 0.170 |
Why?
|
Geographic Mapping | 1 | 2018 | 12 | 0.170 |
Why?
|
Equipment Design | 2 | 2018 | 406 | 0.170 |
Why?
|
Anti-Infective Agents, Local | 1 | 2018 | 23 | 0.170 |
Why?
|
Population Surveillance | 1 | 2020 | 219 | 0.160 |
Why?
|
Truth Disclosure | 1 | 2019 | 87 | 0.160 |
Why?
|
Organizational Affiliation | 1 | 2018 | 6 | 0.160 |
Why?
|
Sex Distribution | 1 | 2018 | 173 | 0.160 |
Why?
|
Demography | 1 | 2018 | 177 | 0.160 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 853 | 0.160 |
Why?
|
China | 2 | 2009 | 228 | 0.160 |
Why?
|
Unemployment | 1 | 2017 | 8 | 0.160 |
Why?
|
Sleep | 1 | 2022 | 444 | 0.160 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 454 | 0.160 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2017 | 2 | 0.160 |
Why?
|
Models, Statistical | 3 | 2019 | 574 | 0.160 |
Why?
|
Personhood | 1 | 2017 | 17 | 0.150 |
Why?
|
Police | 1 | 2017 | 23 | 0.150 |
Why?
|
Health Services Administration | 1 | 2017 | 2 | 0.150 |
Why?
|
Emigrants and Immigrants | 1 | 2018 | 44 | 0.150 |
Why?
|
Financing, Organized | 1 | 2017 | 12 | 0.150 |
Why?
|
Qualitative Research | 2 | 2022 | 256 | 0.150 |
Why?
|
Health Equity | 1 | 2019 | 77 | 0.150 |
Why?
|
Infant, Newborn | 1 | 2023 | 2380 | 0.150 |
Why?
|
Papillomavirus Vaccines | 1 | 2017 | 58 | 0.150 |
Why?
|
Personal Satisfaction | 1 | 2017 | 62 | 0.150 |
Why?
|
Internship and Residency | 1 | 2006 | 1004 | 0.150 |
Why?
|
Community Health Services | 1 | 2018 | 80 | 0.150 |
Why?
|
Focus Groups | 2 | 2019 | 155 | 0.140 |
Why?
|
Genotype | 2 | 2018 | 1851 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 66 | 0.140 |
Why?
|
Marijuana Abuse | 1 | 2016 | 26 | 0.140 |
Why?
|
Hepatitis C | 1 | 2019 | 208 | 0.140 |
Why?
|
Cues | 1 | 2017 | 175 | 0.140 |
Why?
|
Likelihood Functions | 1 | 2016 | 251 | 0.140 |
Why?
|
Cocaine-Related Disorders | 1 | 2016 | 34 | 0.140 |
Why?
|
Drug Monitoring | 1 | 2017 | 118 | 0.140 |
Why?
|
Physician-Patient Relations | 2 | 2016 | 610 | 0.140 |
Why?
|
Transsexualism | 1 | 2016 | 34 | 0.140 |
Why?
|
Reimbursement, Incentive | 1 | 2016 | 37 | 0.140 |
Why?
|
Vaccination | 1 | 2017 | 254 | 0.140 |
Why?
|
Practice Patterns, Physicians' | 3 | 2020 | 582 | 0.140 |
Why?
|
Crime Victims | 1 | 2016 | 34 | 0.130 |
Why?
|
Medicaid | 1 | 2018 | 217 | 0.130 |
Why?
|
Instinct | 1 | 2015 | 2 | 0.130 |
Why?
|
Body Mass Index | 1 | 2019 | 770 | 0.130 |
Why?
|
Psychotherapy, Group | 1 | 2015 | 33 | 0.130 |
Why?
|
Treponema pallidum | 1 | 2015 | 8 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2016 | 361 | 0.130 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 394 | 0.130 |
Why?
|
Paris | 3 | 2019 | 5 | 0.130 |
Why?
|
Ukraine | 3 | 2019 | 14 | 0.130 |
Why?
|
Medicare | 1 | 2018 | 410 | 0.130 |
Why?
|
Needs Assessment | 1 | 2016 | 154 | 0.130 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 141 | 0.130 |
Why?
|
Atlanto-Occipital Joint | 1 | 2014 | 3 | 0.130 |
Why?
|
Atlanto-Axial Joint | 1 | 2014 | 8 | 0.130 |
Why?
|
Trauma, Nervous System | 1 | 2014 | 6 | 0.120 |
Why?
|
Trauma Severity Indices | 1 | 2014 | 41 | 0.120 |
Why?
|
Ligaments, Articular | 1 | 2014 | 36 | 0.120 |
Why?
|
Health Services | 2 | 2019 | 55 | 0.120 |
Why?
|
Thoracic Vertebrae | 1 | 2014 | 49 | 0.120 |
Why?
|
Causality | 1 | 2014 | 81 | 0.120 |
Why?
|
Cognition | 1 | 2019 | 570 | 0.120 |
Why?
|
Community Participation | 1 | 2014 | 36 | 0.120 |
Why?
|
Craniocerebral Trauma | 1 | 2014 | 52 | 0.120 |
Why?
|
Albuterol | 1 | 2014 | 35 | 0.120 |
Why?
|
Delphi Technique | 1 | 2013 | 80 | 0.120 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 130 | 0.120 |
Why?
|
Bronchodilator Agents | 1 | 2014 | 65 | 0.120 |
Why?
|
Lactic Acid | 1 | 2014 | 90 | 0.120 |
Why?
|
Trauma Centers | 1 | 2014 | 116 | 0.120 |
Why?
|
Spinal Fusion | 1 | 2014 | 85 | 0.120 |
Why?
|
Drama | 1 | 2013 | 7 | 0.110 |
Why?
|
Joint Instability | 1 | 2014 | 81 | 0.110 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 1991 | 0.110 |
Why?
|
Quality of Life | 2 | 2020 | 1585 | 0.110 |
Why?
|
Occupations | 1 | 2012 | 26 | 0.110 |
Why?
|
Telephone | 1 | 2012 | 32 | 0.110 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2012 | 10 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2012 | 24 | 0.110 |
Why?
|
Leadership | 1 | 2014 | 134 | 0.110 |
Why?
|
Prejudice | 1 | 2012 | 49 | 0.110 |
Why?
|
Spouses | 1 | 2012 | 33 | 0.110 |
Why?
|
Molecular Sequence Data | 1 | 2016 | 3030 | 0.100 |
Why?
|
Child | 2 | 2020 | 6927 | 0.100 |
Why?
|
Tracheostomy | 1 | 2012 | 42 | 0.100 |
Why?
|
Extramarital Relations | 1 | 2011 | 1 | 0.100 |
Why?
|
Treatment Failure | 1 | 2012 | 285 | 0.100 |
Why?
|
Coitus | 1 | 2011 | 20 | 0.100 |
Why?
|
Marital Status | 1 | 2011 | 40 | 0.100 |
Why?
|
Social Class | 1 | 2012 | 128 | 0.100 |
Why?
|
Epidemiologic Research Design | 1 | 2011 | 22 | 0.100 |
Why?
|
Sodium, Dietary | 1 | 2011 | 13 | 0.100 |
Why?
|
Hyponatremia | 1 | 2011 | 25 | 0.100 |
Why?
|
Oxygen Consumption | 1 | 2012 | 239 | 0.100 |
Why?
|
Health Care Coalitions | 1 | 2011 | 9 | 0.100 |
Why?
|
Length of Stay | 1 | 2014 | 702 | 0.100 |
Why?
|
Attitude to Health | 1 | 2012 | 220 | 0.100 |
Why?
|
Community-Institutional Relations | 1 | 2011 | 29 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2011 | 55 | 0.090 |
Why?
|
Registries | 1 | 2014 | 702 | 0.090 |
Why?
|
Pediatrics | 1 | 2014 | 344 | 0.090 |
Why?
|
Women's Health Services | 1 | 2009 | 15 | 0.090 |
Why?
|
Sodium | 1 | 2011 | 341 | 0.090 |
Why?
|
Public Sector | 1 | 2009 | 12 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2012 | 351 | 0.090 |
Why?
|
Molecular Epidemiology | 2 | 2020 | 53 | 0.090 |
Why?
|
New York City | 2 | 2020 | 59 | 0.080 |
Why?
|
HIV Serosorting | 2 | 2018 | 3 | 0.080 |
Why?
|
Social Environment | 2 | 2020 | 188 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 865 | 0.080 |
Why?
|
Vaginal Discharge | 1 | 2007 | 2 | 0.080 |
Why?
|
Warts | 1 | 2007 | 11 | 0.080 |
Why?
|
Ulcer | 1 | 2007 | 36 | 0.080 |
Why?
|
Therapeutic Irrigation | 1 | 2007 | 60 | 0.080 |
Why?
|
Diet | 1 | 2011 | 443 | 0.080 |
Why?
|
Machine Learning | 2 | 2020 | 232 | 0.080 |
Why?
|
Infant | 1 | 2014 | 3047 | 0.080 |
Why?
|
Hospitals, University | 1 | 2008 | 194 | 0.080 |
Why?
|
Mucous Membrane | 1 | 2007 | 83 | 0.080 |
Why?
|
Immunoglobulin A | 1 | 2007 | 80 | 0.080 |
Why?
|
Physicians | 1 | 2014 | 673 | 0.070 |
Why?
|
Conflict of Interest | 1 | 2006 | 67 | 0.070 |
Why?
|
Vitamin D | 1 | 2008 | 261 | 0.070 |
Why?
|
Hospitalization | 3 | 2022 | 849 | 0.070 |
Why?
|
Research Design | 2 | 2020 | 594 | 0.070 |
Why?
|
Asthma | 1 | 2014 | 955 | 0.070 |
Why?
|
Immunoglobulin G | 1 | 2007 | 456 | 0.070 |
Why?
|
Interprofessional Relations | 1 | 2006 | 121 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2007 | 912 | 0.070 |
Why?
|
Pain | 1 | 2007 | 391 | 0.060 |
Why?
|
Factor Analysis, Statistical | 1 | 2004 | 111 | 0.060 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2004 | 8 | 0.060 |
Why?
|
Iowa | 1 | 2004 | 35 | 0.060 |
Why?
|
Hospitals, Community | 1 | 2004 | 32 | 0.060 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2004 | 28 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2020 | 6509 | 0.060 |
Why?
|
Pheochromocytoma | 1 | 2004 | 49 | 0.060 |
Why?
|
Patient Admission | 1 | 2004 | 112 | 0.060 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2004 | 80 | 0.060 |
Why?
|
Parental Consent | 1 | 2023 | 35 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2007 | 1805 | 0.060 |
Why?
|
Neoplasms | 1 | 2017 | 2898 | 0.050 |
Why?
|
Employment | 1 | 2022 | 52 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 3362 | 0.050 |
Why?
|
Naloxone | 1 | 2022 | 59 | 0.050 |
Why?
|
Policy | 1 | 2022 | 34 | 0.050 |
Why?
|
Case Management | 1 | 2021 | 24 | 0.050 |
Why?
|
Lost to Follow-Up | 1 | 2021 | 12 | 0.050 |
Why?
|
Needle Sharing | 1 | 2020 | 14 | 0.050 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 1 | 0.050 |
Why?
|
Informed Consent | 1 | 2023 | 266 | 0.050 |
Why?
|
Parents | 1 | 2023 | 272 | 0.050 |
Why?
|
Regression Analysis | 2 | 2013 | 596 | 0.050 |
Why?
|
Florida | 1 | 2019 | 55 | 0.040 |
Why?
|
Mississippi | 1 | 2019 | 3 | 0.040 |
Why?
|
New Orleans | 1 | 2019 | 6 | 0.040 |
Why?
|
Africa | 1 | 2019 | 98 | 0.040 |
Why?
|
Homophobia | 1 | 2019 | 4 | 0.040 |
Why?
|
Epidemiological Monitoring | 1 | 2019 | 39 | 0.040 |
Why?
|
Knowledge | 1 | 2019 | 29 | 0.040 |
Why?
|
Administration, Oral | 1 | 2020 | 684 | 0.040 |
Why?
|
Europe | 1 | 2019 | 309 | 0.040 |
Why?
|
Europe, Eastern | 1 | 2018 | 3 | 0.040 |
Why?
|
Mouth | 1 | 2018 | 48 | 0.040 |
Why?
|
Research Personnel | 1 | 2019 | 67 | 0.040 |
Why?
|
New York | 1 | 2018 | 69 | 0.040 |
Why?
|
Penis | 1 | 2018 | 57 | 0.040 |
Why?
|
Genotyping Techniques | 1 | 2018 | 68 | 0.040 |
Why?
|
Asia | 1 | 2018 | 95 | 0.040 |
Why?
|
Economic Competition | 1 | 2017 | 12 | 0.040 |
Why?
|
Disease Outbreaks | 1 | 2018 | 154 | 0.040 |
Why?
|
Mobile Applications | 1 | 2018 | 63 | 0.040 |
Why?
|
Interinstitutional Relations | 1 | 2017 | 28 | 0.040 |
Why?
|
Exercise | 1 | 2020 | 315 | 0.040 |
Why?
|
Risk | 1 | 2018 | 674 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 827 | 0.040 |
Why?
|
London | 1 | 2016 | 16 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 73 | 0.030 |
Why?
|
Directive Counseling | 1 | 2015 | 34 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2015 | 37 | 0.030 |
Why?
|
Health Care Costs | 1 | 2017 | 238 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 456 | 0.030 |
Why?
|
Family | 1 | 2016 | 311 | 0.030 |
Why?
|
Algorithms | 1 | 2023 | 1830 | 0.030 |
Why?
|
Ipratropium | 1 | 2014 | 18 | 0.030 |
Why?
|
Spirometry | 1 | 2014 | 66 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2014 | 122 | 0.030 |
Why?
|
Societies, Medical | 1 | 2017 | 572 | 0.030 |
Why?
|
Prednisone | 1 | 2014 | 258 | 0.030 |
Why?
|
Self Report | 1 | 2014 | 288 | 0.030 |
Why?
|
Linear Models | 1 | 2014 | 421 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 136 | 0.030 |
Why?
|
Safety Management | 1 | 2012 | 56 | 0.030 |
Why?
|
Animals | 1 | 2011 | 26582 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2012 | 64 | 0.030 |
Why?
|
Pressure | 1 | 2012 | 165 | 0.030 |
Why?
|
Middle East | 1 | 2011 | 17 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 894 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2014 | 352 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2012 | 278 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2011 | 27 | 0.020 |
Why?
|
Models, Organizational | 1 | 2011 | 46 | 0.020 |
Why?
|
Software | 1 | 2014 | 654 | 0.020 |
Why?
|
Seasons | 1 | 2011 | 223 | 0.020 |
Why?
|
Preoperative Care | 1 | 2012 | 397 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2014 | 1823 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2012 | 334 | 0.020 |
Why?
|
Disease Progression | 1 | 2014 | 1531 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2009 | 153 | 0.020 |
Why?
|
Biomarkers | 1 | 2014 | 1718 | 0.020 |
Why?
|
Mobile Health Units | 1 | 2007 | 11 | 0.020 |
Why?
|
Tracheotomy | 1 | 2007 | 18 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 636 | 0.020 |
Why?
|
Chronic Disease | 1 | 2008 | 971 | 0.020 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2004 | 104 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 920 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 826 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2004 | 318 | 0.010 |
Why?
|
Pregnancy | 1 | 2004 | 2894 | 0.010 |
Why?
|